Vanguard Pharmaceutical wins sales contract from Arbro
Vanguard’s strategic alliance with Arbro is expected to ensure delivery of quality products at affordable prices. Vanguard said that it has performed a market price analysis of Arbro’s
The US Food and Drug Administration (FDA) has granted rare paediatric disease designation to Vanda Pharmaceuticals’ VCA-894A, an investigational antisense oligonucleotide therapy for Charcot-Marie-Tooth disease, axonal, type 2S (CMT2S).
The study evaluated the efficacy, safety and tolerability of an innovative, proprietary, 28mg once-daily extended-release formulation of Namenda (memantine HCl) compared to placebo in outpatients with moderate to